Unknown

Dataset Information

0

Ultrastructural and diffusion tensor imaging studies reveal axon abnormalities in Pompe disease mice.


ABSTRACT: Pompe disease (PD) is caused by lysosomal glycogen accumulation in tissues, including muscles and the central nervous system (CNS). The intravenous infusion of recombinant human acid alpha-glucosidase (rhGAA) rescues the muscle pathologies in PD but does not treat the CNS because rhGAA does not cross the blood-brain barrier (BBB). To understand the CNS pathologies in PD, control and PD mice were followed and analyzed at 9 and 18 months with brain structural and ultrastructural studies. T2-weighted brain magnetic resonance imaging studies revealed the progressive dilatation of the lateral ventricles and thinning of the corpus callosum in PD mice. Electron microscopy (EM) studies at the genu of the corpus callosum revealed glycogen accumulation, an increase in nerve fiber size variation, a decrease in the g-ratio (axon diameter/total fiber diameter), and myelin sheath decompaction. The morphology of oligodendrocytes was normal. Diffusion tensor imaging (DTI) studies at the corpus callosum revealed an increase in axial diffusivity (AD) and mean diffusivity (MD) more significantly in 9-month-old PD mice. The current study suggests that axon degeneration and axon loss occur in aged PD mice and are probably caused by glycogen accumulation in neurons. A drug crossing the BBB or a treatment for directly targeting the brain might be necessary in PD.

SUBMITTER: Lee NC 

PROVIDER: S-EPMC7677380 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ultrastructural and diffusion tensor imaging studies reveal axon abnormalities in Pompe disease mice.

Lee Ni-Chung NC   Peng Wei-Hao WH   Tsai Li-Kai LK   Lu Yen-Hsu YH   Wang Hao-Chun HC   Shih Yao-Chia YC   Pung Zeng-Xian ZX   Hu Hsi-Yuan HY   Hwu Wuh-Liang WL   Tseng Wen-Yih Isaac WI   Chien Yin-Hsiu YH  

Scientific reports 20201119 1


Pompe disease (PD) is caused by lysosomal glycogen accumulation in tissues, including muscles and the central nervous system (CNS). The intravenous infusion of recombinant human acid alpha-glucosidase (rhGAA) rescues the muscle pathologies in PD but does not treat the CNS because rhGAA does not cross the blood-brain barrier (BBB). To understand the CNS pathologies in PD, control and PD mice were followed and analyzed at 9 and 18 months with brain structural and ultrastructural studies. T2-weight  ...[more]

Similar Datasets

| S-EPMC5280002 | biostudies-literature
| S-EPMC4482724 | biostudies-literature
| S-EPMC6869949 | biostudies-literature
| S-EPMC6754492 | biostudies-literature
| S-EPMC4990171 | biostudies-literature
| S-EPMC3671993 | biostudies-other
| S-EPMC6593682 | biostudies-literature
| S-EPMC6698319 | biostudies-literature
| S-EPMC7063983 | biostudies-literature
| S-EPMC5560677 | biostudies-other